Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D B Mendel

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Science (New York, N.Y.)|December 20, 1991
Characterization of a cofactor that regulates dimerization of a mammalian homeodomain proteinD B Mendel, P A Khavari, P B Conley, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
A new series of C3-aza carbocyclic influenza neuraminidase inhibitors: synthesis and inhibitory activityW Lew, H Wu, D B Mendel, et al.
Antiviral Research|January 27, 1998
In vitro characterization of the anti-human cytomegalovirus activity of PMEA (Adefovir)X Xiong, C Flores, M D Fuller, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2000
Carbocyclic influenza neuraminidase inhibitors possessing a C3-cyclic amine side chain: synthesis and inhibitory activityW Lew, H Wu, X Chen, et al.
Antimicrobial Agents and Chemotherapy|December 3, 1998
Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071C Y Tai, P A Escarpe, R W Sidwell, et al.
Bioorganic & Medicinal Chemistry Letters|July 16, 1999
Synthesis and evaluation of 1,4,5,6-tetrahydropyridazine derivatives as influenza neuraminidase inhibitorsL Zhang, M A Williams, D B Mendel, et al.
Genes & Development|March 1, 1990
HNF-1 shares three sequence motifs with the POU domain proteins and is identical to LF-B1 and APFS Baumhueter, D B Mendel, P B Conley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2001
The angiogenesis inhibitor SU5416 has long-lasting effects on vascular endothelial growth factor receptor phosphorylation and functionD B Mendel, R E Schreck, D C West, et al.
Antiviral Research|July 10, 2002
The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivoJ A L Ives, J A Carr, D B Mendel, et al.
Journal of Medicinal Chemistry|July 3, 1998
Structure-activity relationship studies of novel carbocyclic influenza neuraminidase inhibitorsC U Kim, W Lew, M A Williams, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Science (New York, N.Y.)|December 20, 1991
Characterization of a cofactor that regulates dimerization of a mammalian homeodomain proteinD B Mendel, P A Khavari, P B Conley, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
A new series of C3-aza carbocyclic influenza neuraminidase inhibitors: synthesis and inhibitory activityW Lew, H Wu, D B Mendel, et al.
Antiviral Research|January 27, 1998
In vitro characterization of the anti-human cytomegalovirus activity of PMEA (Adefovir)X Xiong, C Flores, M D Fuller, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2000
Carbocyclic influenza neuraminidase inhibitors possessing a C3-cyclic amine side chain: synthesis and inhibitory activityW Lew, H Wu, X Chen, et al.
Antimicrobial Agents and Chemotherapy|December 3, 1998
Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071C Y Tai, P A Escarpe, R W Sidwell, et al.
Bioorganic & Medicinal Chemistry Letters|July 16, 1999
Synthesis and evaluation of 1,4,5,6-tetrahydropyridazine derivatives as influenza neuraminidase inhibitorsL Zhang, M A Williams, D B Mendel, et al.
Genes & Development|March 1, 1990
HNF-1 shares three sequence motifs with the POU domain proteins and is identical to LF-B1 and APFS Baumhueter, D B Mendel, P B Conley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2001
The angiogenesis inhibitor SU5416 has long-lasting effects on vascular endothelial growth factor receptor phosphorylation and functionD B Mendel, R E Schreck, D C West, et al.
Antiviral Research|July 10, 2002
The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivoJ A L Ives, J A Carr, D B Mendel, et al.
Journal of Medicinal Chemistry|July 3, 1998
Structure-activity relationship studies of novel carbocyclic influenza neuraminidase inhibitorsC U Kim, W Lew, M A Williams, et al.
Pageof 5